Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Zug, Switzerland:    Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™

READ MORE

SMT Launches Hydra TAVI System in Hungary, Expands Global Footprint with Positive Early Results

Sahajanand Medical Technologies Ltd. (SMT)   Mumbai, Maharashtra, India:  SMT (Sahajanand Medical Technologies), a global leader in innovative vascular solutions, announces

READ MORE

Stayble Therapeutics’ STA363 receives positive phase 1b results

Stayble Therapeutics AB (“Stayble” or the “Company”) announces positive results from the Company’s clinical phase 1b study in lumbar disc herniation

READ MORE

ExpreS2ion and Evaxion announce positive preclinical data for cytomegalovirus (CMV) vaccine program ES2B-I002

Hørsholm, Denmark, 12 November 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a clinical-stage biotechnology company with

READ MORE

Cinis ships additional vessel with potassium sulfate and achieves positive cash flow

Today, Cinis Fertilizer sends a new shipload of water-soluble potassium sulfate of the highest quality to Van Iperen International. The

READ MORE

Swedavia’s quarterly report for July–September 2024: More passengers and higher commercial revenue contributed to increased net revenue, strengthened operating income and positive profit before tax

A positive international travel trend, higher commercial revenues and fee adjustments strengthened Swedavia’s net revenue during the third quarter of

READ MORE

BioStock: Cereno’s phase IIa results positive, clear path forward

Thu, Oct 03, 2024 08:43 CET Report this content Recently, Cereno Scientific announced positive topline results from the

READ MORE

Edison Investment Research increases valuation of Cereno Scientific to 3.9 BSEK or SEK 13.9 SEK/share after positive topline data

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, today announced

READ MORE

Cereno Scientific announces positive topline results of Phase IIa trial with lead candidate CS1 in Pulmonary Arterial Hypertension

Primary endpoint of safety and tolerability met successfully Positive impact on exploratory clinical efficacy parameters: REVEAL risk score: 43% (9/21) of

READ MORE

Inside information, positive profit warning: HKFoods Plc’s comparable EBIT from continuing operations will grow clearly compared to 2023

HKFoods Plc, stock exchange release, inside information, 26 September 2024 at 2 p.m. Finnish time HKFoods Plc updates its financial guidance

READ MORE